Elevance Health
$381.67Change from previous close: −1.84%Absolute change: −$7.15
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $82.77B
- Enterprise value
- $76.44B
- P/E (trailing 12 months)
- 16.9
- Forward P/E
- 12.9
- PEG
- 1.27
- Price/book
- 1.84
- Price/sales
- 0.41
- EV/EBITDA
- 9.18
- EV/revenue
- 0.38
Profitability and growth
- Gross margin
- 26.0%
- Operating margin
- 4.6%
- Net margin
- 2.5%
- ROE
- 11.1%
- ROA
- 3.8%
- Revenue growth (year over year)
- 1.4%
- Earnings growth (year over year)
- -13.1%
Financial health
- Total cash
- $37.51B
- Total debt
- $31.04B
- Debt/equity
- 0.69
- Current ratio
- 1.52
- Quick ratio
- 1.37
Dividends
- Annual dividend per share
- $6.88
- Dividend yield
- 1.8%
- Payout ratio
- 30.3%
- Ex-dividend date
- September 10, 2026
Analysts and estimates
- Average price target
- $451.38
- Median price target
- $460.00
- High price target
- $492.00
- Low price target
- $393.00
- Analysts with a price target
- 21
- Consensus
- Buy
- Forward EPS
- $29.54
- EPS estimate, current year
- $27.17
Shares and trading
- Beta
- 0.70
- Average volume
- 1.22M
- Shares outstanding
- 216.87M
- Float
- 216.37M
- Institutional ownership
- 94.1%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 2.8%
- Short ratio (days)
- 5.12